Evaluation of efficacy and safety of temozolomide and silibinin on the patients with glioblastoma

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: c8c9d4356f48c8136d055248b13329955b970a7b
First added on: Apr 23, 2026